Takayasu’s arteritis (TA) is a chronic inflammatory and fibrosing arteriopathy that can also involve cutaneous vessels. The disease typically presents with a prepulseless phase that overlaps or is followed by the characteristic pulseless stage. In both phases of TA, cutaneous manifestations may be present. Lesions considered to be ‘specifically’ associated with TA have been described most frequently simulating erythema nodosum, erythema induratum and pyoderma gangrenosum. We report 2 Caucasian patients with TA and nodular cutaneous lesions. Nine skin biopsies from these patients were studied. A necrotizing vasculitis was present in 5 biopsies. We review those patients with TA and well-documented cutaneous manifestations in the English literature, with special interest in nodular lesions, the most frequent cutaneous manifestation of TA in Caucasian patients. Biopsies from lesions with similar morphology frequently show different histological findings.

Keywords:
Cutaneous polyarteritis nodosa, Skin nodules, Takayasu’s disease, Vasculitis
1.
Ishikawa K: Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 1988;12:964–972.
2.
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al: The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129–1134.
3.
Sharma BK, Jain S, Suri S, Numano F: Diagnostic criteria for Takayasu arteritis. Int J Cardiol 1996;54:S141–S147.
4.
Mousa ARM, Marafie AA, Dajani AI: Cutaneous necrotizing vasculitis complicating Takayasu’s arteritis with a review of cutaneous manifestations. J Rheumatol 1985;12:607–610.
5.
Leavitt RY, Fauci AS: Polyangiitis overlap syndrome. Classification and prospective clinical experience. Am J Med 1986;81:79–85.
6.
Cajigas JC, Amigo MC, Pineda C, Herrera R, Sanchez-Torres G, Martínez-Lavin M: Association between Takayasu’s arteritis and cutaneous polyarteritis nodosa. Am J Med 1987;82:382–384.
7.
Perniciaro CV, Winkelmann RK, Hunder GG: Cutaneous manifestations of Takayasu’s arteritis: A clinicopathologic correlation. J Am Acad Dermatol 1987;17:998–1005.
8.
Francès C, Boisnic S, Blétry O, Dallot A, Thomas D, Kieffer E, et al: Cutaneous manifestations of Takayasu arteritis: A retrospective study of 80 cases. Dermatologica 1990;181:266–272.
9.
Werfel T, Kuipers JG, Zeidler H, Kapp A, Kiehl P: Cutaneous manifestations of Takayasu arteritis. Acta Derm Venereol (Stockh) 1996;76:496–497.
10.
Skaria AM, Ruffieux P, Piletta P, Chavaz P, Saurat JH, Borradori L: Takayasu arteritis and cutaneous necrotizing vasculitis. Dermatology 2000;200:139–143.
11.
Taïeb A, Dufillot D, Pellegrin-Carloz B, Calabet A, Clémenty J, Guillard JM, et al: Postgranulomatous anetoderma associated with Takayasu’s arteritis in a child. Arch Dermatol 1987;123:796–800.
12.
Fearfield LA, Ross JR, Farrell AM, Costello C, Bunker CB, Staughton RCD: Pyoderma gangrenosum associated with Takayasu’s arteritis responding to cyclosporin. Br J Dermatol 1999;141:339–343.
13.
Hidano A, Watanabe K: Pyoderma gangrenosum et cardiovasculopathies, en particulier artérite de Takayasu: revue de la littérature japonaise. Ann Dermatol Vénéréol 1981;108:13–21.
14.
Nakao K, Ikeda M, Kimata SI, Niitani H, Niyahara M: Takayasu’s arteritis: Clinical report of eighty-four cases and immunological studies of seven cases. Circulation 1967;35:1141–1155.
15.
Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE: Takayasu’s arteritis: Clinical study of 107 cases. Am Heart J 1977;93:94–103.
16.
Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y: Inflammation and atherosclerosis: Atherosclerotic lesions in Takayasu arteritis. Ann NY Acad Sci 2000;902:65–76.
17.
Weirner N: Giant-cell vasculitides. Semin Diagn Pathol 2001;18:24–33.
18.
Gravanis MB: Giant cell arteritis and Takayasu aortitis: Morphologic, pathogenetic and etiologic factors. Int J Cardiol 2000;75:S21–S33.
19.
Johnston SL, Lock RJ, Gompels MM: Takayasu arteritis: A review. J Clin Pathol 2002;55:481–486.
20.
Hoffman GS, Ahmed AE: Surrogate markers of disease activity in patients with Takayasu arteritis: A preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998;66:S191–S194.
21.
Numano F, Okawara M, Inomata H, Kobayashi Y: Takayasu’s arteritis. Lancet 2000;356:1023–1025.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.